SCHEMBL10240616

SCHEMBL10240616

CCN1CCc2c(cccc2N(CC)S(=O)(=O)c2sc3ccc(Cl)cc3c2C)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.41
HTR6 P50406 13/20 0.39
PFKFB3 Q16875 3/20 0.37
PFKFB4 Q16877 3/20 0.37
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CMA1 P23946 1/20 0.37
HTR1A P08908 1/20 0.36
DRD2 P14416 1/20 0.36
HTR1D P28221 1/20 0.36
HTR1B P28222 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR1E P28566 1/20 0.36
HTR1F P30939 1/20 0.36
HTR7 P34969 1/20 0.36
ADRA1B P35368 1/20 0.36
DRD3 P35462 1/20 0.36
HTR2B P41595 1/20 0.36
HTR4 Q13639 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4509681 0.99 SLC2A1 (0.42) SLC2A1HTR6PFKFB3PFKFB4NPSR1
SCHEMBL2953473 0.70 NPSR1 (0.54) SLC2A1HTR6PFKFB3PFKFB4NPSR1
SCHEMBL10238827 0.70 HTR6 (0.41) HTR6HTR2CHTR7HTR2B
Hydrochloric Acid SCHEMBL4512674 0.69 HTR6 (0.41) HTR6HTR2CHTR7HTR2B
SCHEMBL4712317 0.68 ALDH1A1 (0.36) HTR6HTR7
Hydrochloric Acid SCHEMBL4515540 0.68 ALDH1A1 (0.36) HTR6HTR7
SCHEMBL10035547 0.67 HTR7 (0.55) HTR6HTR1ADRD2HTR2AHTR2C
SCHEMBL8979950 0.67 HTR7 (0.56) HTR6HTR1ADRD2HTR2AHTR2C
Hydrochloric Acid SCHEMBL2135275 0.67 HTR7 (0.54) HTR6HTR1ADRD2HTR2AHTR2C
SCHEMBL8982971 0.66 HTR7 (0.55) HTR6HTR1ADRD2HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2007729-B1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS ESTEVE LABOR DR (ES) 2012-06-27 EP disclosed
US-20090209528-A1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUND, THEIR PREPARATION AND USE IN MEDICAMENTS LABORATORIOS DEL DR. ESTEVE S.A. (ES) 2009-08-20 US disclosed
US-20090209528-A1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUND, THEIR PREPARATION AND USE IN MEDICAMENTS LABORATORIOS DEL DR. ESTEVE S.A. (ES) 2009-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209528-A1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUND, THEIR PREPARATION AND USE IN MEDICAMENTS HTR6, HTR5A, HTR7 SLC2A1 2626/4885HTR6 1/4885PFKFB3 2910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.